This announcement is a separate document:
方正证券承销保荐有限责任公司关于上海赛伦生物技术股份有限公司2023年度持续督导跟踪报告
Fangzheng Securities Underwriting and Sponsorship Co., Ltd. report on the 2023 continuous supervision and follow-up report of Shanghai Sailun Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.